Format

Send to

Choose Destination

RETRACTED ARTICLE

See: Retraction Notice

JAMA. 2014 Apr 9;311(14):1440-1. doi: 10.1001/jama.2014.1404.

Oral zinc for the common cold.

Author information

1
Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, India.
2
Department of Pediatrics, Post-Graduate Institute of Medical Education and Research, Chandigarh, India.

Abstract

CLINICAL QUESTION:

Is oral zinc associated with a shorter duration, decreased severity, and reduced incidence of the common cold compared with placebo?

BOTTOM LINE:

When initiated within 24 hours of symptom onset, oral zinc is associated with a shorter duration of the common cold in healthy people. However, there is no association between oral zinc and symptom severity, and the prevalence of adverse effects with zinc lozenges is high. Given the high heterogeneity of data, these results should be interpreted with caution. Used prophylactically, oral zinc is associated with a reduced cold incidence in children. Prophylactic use has not been studied in adults.

Comment on

PMID:
24715076
DOI:
10.1001/jama.2014.1404
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center